Mackenzie Financial Corp Organogenesis Holdings Inc. Transaction History
Mackenzie Financial Corp
- $63.2 Billion
- Q2 2024
A detailed history of Mackenzie Financial Corp transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 24,328 shares of ORGO stock, worth $68,604. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,328
Previous 16,650
46.11%
Holding current value
$68,604
Previous $47,000
44.68%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ORGO
# of Institutions
120Shares Held
62.3MCall Options Held
28.8KPut Options Held
27.9K-
Morgan Stanley New York, NY11.6MShares$32.6 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT11.5MShares$32.5 Million3.27% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$14.3 Million0.0% of portfolio
-
Assenagon Asset Management S.A.3.98MShares$11.2 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$10 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $369M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...